Tatsat Chronicle Magazine

AYUSH medicines proved effective in post-Covid issues: Minister

September 1, 2021
AYUSH

Minister of State for Ayush Dr. Munjpara Mahendrabhai said that Ayush medicines have proved effective in dealing with post-Covid issues. The Ministry of Ayush regularly issued protocols to combat Covid-19 and people have benefited in a big way from medicines like Giloy. The Minister said “There have been several clinical studies on Ayush practices and more research is required in the sector. The Ministry of Ayush welcomes those who want to do research in Ayush” he added.

The Minister was addressing a webinar organized by the All India Institute of Ayurveda under the Ministry of AYUSH, on the role of the AYUSH system in the management of COVID-19. The event was organized as the first in a series of week-long AYUSH programmes under ‘Azadi Ka Amrit Mahotsav’, a celebration to commemorate 75 years of India’s freedom next year.

Addressing the webinar, the Joint Secretary, Ministry of Ayush, Mr. D Senthil Pandian said that while the entire country was preparing to fight the third wave of Covid-19 pandemic, the Ministry of Ayush has also prepared a blueprint. He added that the infrastructure of the AYUSH sector was expected to be ramped up in the coming days to make the benefits of Ayush systems available to the people of the country at a wider level.

Explaining the benefits of the Ayurveda and other streams of Ayush in the management of mild and moderate cases of Covid-19, Dr. Tanuja Nesari, Director, All India Institute of Ayurveda said that the recovery rate at the Covid center set up at the institute has been more than 99 percent. “Not only were the corona-infected patients cured in the Covid Centre, but there was also no loss of life even among the doctors, nursing staff, and other hospital staff engaged in their treatment. The biggest reason for this was that everyone followed the Ayush protocol. I myself take Ayush medicines and am healthy for the last two years,” she said.


For , Follow Tatsat Chronicle on FacebookTwitter and get connected to us on LinkedIn